Our training program is a Council for Graduate Medical Education-accredited 12-month intensive clinical hematopathology rotation. Each year we appoint one fellow to train within the Department of Medicine’s Division of Hematology and Department of Pathology’s Division of Hematopathology. Our fellowship is a two-year experience, with the first year as an Accreditation Council for Graduate Medical Education-approved year.
Historically, the institution has made a number of important contributions to the field including: development of blood banking, understanding of the pathophysiology of polycythemia vera, fundamental role of tissue factor in blood clotting, and the advancement of new therapies for sickle cell disease and hemophilia. We provide cutting-edge, timely, integrated and contemporary diagnoses in nodal,extranodal tissues, bone marrow, and fluids such as peripheral bloods, reviewing more than 1,500 cases each year, submitted by pathologists and hematologists, oncologists locally, nationally and internationally.
We offer expert hematopathology consultation services. Morphologic assessment is key and remains the cornerstone for diagnostic classification in hematologic malignancies. Further ancillary work up such as special stains, phenotyping, genomics, FISH, GEP, and NGS provide further tools for molecular subclassification in the current era of precision medicine and immunotherapeutics.
In 2016-2017, the Division reviewed approximately 49,152 slides from bone marrow biopsies, smears, nodal, extranodal, and body fluids (CSF, Pleural fluids, peripheral blood), performed 507,619 CBCs, 4,388 flow cytometry assays, 2,094 karyotypes, 11,391 FISH assays, 11,931 Molecular (DNA) assays, 2,363 immunohistochemical assays, and 322,172 special coagulation assays
Our faculty include: